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Abstract A proportion of episodic migraine patients experi-
ences a progressive increase in attack frequency leading to
chronic migraine (CM). The most frequent external factor that
leads to headache chronification is medication overuse. The
neurobiological bases of headache chronification and of the
vicious circle of medication overconsumption are not com-
pletely elucidated. More recently, the same neurophysiolog-
ical methods used to study episodic migraine were applied to
CM and medication-overuse headache (MOH). Studies of
cortical responsivity tend overall to indicate an increase in
excitability, in particular of somatosensory and visual cortices,
reflected by increased amplitude of evoked responses,
decreased activity of inhibitory cortical interneurons reflected
in the smaller magnetic suppression of perceptual accuracy,
and, at least for visual responses, an increase in habituation. In
MOH, overconsumption of triptans or NSAIDs influences
cortical excitability differently. Generalized central sensitiza-
tion is suggested to play an important role in the pathophys-
iology of headache chronification.
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Introduction
Episodic migraine is characterized by the cyclic recurrence
of headaches, separated by attack-free periods, of which the
exact pathogenesis is still not completely known. Important
insights into the pathophysiology of migraine were gained
during the past decade, confirming that inherited and
environmental factors are interrelated.
The genetic vulnerability to migraine, the so-called
genetic migraine threshold, could be reflected phenotypi-
cally by increased responsiveness of the cerebral cortex to
sensory information, dysfunctioning brainstem neurons,
reduced mitochondrial energy reserve, and NO hypersensi-
tivity among others.
A proportion of episodic migraine patients experiences a
progressive increase in attack frequency leading to chronic
migraine (CM), defined as 15 or more headache days with 8 or
more migraine attacks per month [1]. Various intrinsic and
external factors can favor migraine chronification. The most
frequent finding in clinical practice is medication-overuse
headache (MOH) that is diagnosed in up to 80% of patients
attending specialized headache clinics [1–3]. Although any
primary headache can evolve to MOH, migraine is by far the
most prevalent type. A history of frequent migraine and
analgesic overuse are the most prominent risk factors for
developing chronic daily headache (CDH) [4, 5]. All known
treatments taken for symptomatic headache relief, such as
triptans, analgesics, and opioids, can induce transformation
from episodic headache to MOH, though NSAIDs seem less
prone to do so [1, 3].
The neurobiological bases of headache chronification
and of the vicious circle of medication overconsumption are
not completely understood.
During the past decades, electrophysiological methods
were particularly useful for the understanding of certain
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facets of migraine pathophysiology because they are able to
detect functional brain abnormalities and they can be repeated
noninvasively and at low cost. Most evoked-potential studies
have shown that, for a number of different sensory modalities,
the migrainous brain is characterized between attacks by
deficient habituation brain potentials during stimulus repeti-
tion. This abnormality of cortical responsivity fluctuates over
time in relation to the migraine attack; it is most pronounced
during the days immediately preceding the attack and
normalizes during the attack [6]. More recently, the same
methods were applied to CM patients, and in particular to
those with associated medication overuse.
This article focuses on the available neurophysiological
data providing information about cortical responsiveness
reactivity in patients who evolved from episodic migraine
to CM with or without medication overuse.
Published Data
Although the precise mechanisms underlying headache
chronification are not fully understood, central sensitization
and dysfunctioning pain control systems are thought to play
pivotal roles. The available published data are shown in
Table 1.
Pain-Related Responses
Abnormalities of pain-related brain responses can be
recorded in episodic migraine. It was assumed that these
abnormalities would be even more marked in CM.
Brief radiant CO2 laser stimulations are able to activate
small Aδ and C thermal nociceptors in superficial skin [7].
They have been used in the cranial or extracranial territories
to elicit nociceptive evoked brain responses.
In episodic migraine, during the interictal phase, the
negative-positive biphasic wave (N2-P2) laser-evoked
potential (LEP) complex, which is chiefly generated in the
anterior cingulate cortex, is normal in basal conditions after
both cranial and extracranial stimulations. However, LEPs
are abnormally modulated by heterotopic conditioning
stimuli such as remote capsaicin application [8] and by
distraction [9, 10].
By contrast, in a group of 25 CM patients, a trend for an
excessive increase in LEP N2-P2 amplitudes was detected
at baseline [9]. This is less pronounced when the stimulus
becomes painful and with increasing disease duration. The
authors interpreted their results as evidence for a functional
reorganization of the cortical pain matrix due to the attack
repetition, a phenomenon similar to that described in other
long-lasting pain conditions [9]. In fact, in a brain-mapping
analysis of the cortical source of the most prominent LEP
peak (P2), the same authors found that after supraorbital
laser stimulation, CM patients were characterized by more
pronounced activation of the rostral portion of the anterior
cingulate cortex than episodic migraineurs and normal
controls [11]. In addition, they observed that this positional
shift of the P2 dipole, as expressed by its x-coordinate, was
significantly correlated with headache frequency, but not
with other clinical features or with greater self-evaluated
depression and anxiety [11].
In a group of 29 migraine patients who evolved to CDH
due to medication overuse, Ayzenberg et al. [12] recorded
simultaneously blink reflex and pain-related evoked poten-
tials (PREPs) after electrical stimulations of the forehead or
the hand dorsum, respectively, with a planar concentric
stimulating electrode selectively activating Aδ fibers. They
observed a significant increase in PREP amplitudes in all
patients with MOH whether they overused analgesics or
triptans. PREP amplitudes were increased both after
cephalic and extracephalic stimulation and were not related
to self-perceived depressive mood. Discontinuation of the
acute medication overuse tended to normalize the PREP
amplitude [12]. By contrast, nociception-specific blink
reflexes were normal, suggesting that sensitization takes
place at the suprasegmental level in MOH patients.
Non-noxious Somatosensory Evoked Potentials
Somatosensory evoked potentials (SSEPs) are generated in
afferent pathways, subcortical structures, and various regions
of the cerebral cortex after galvanic stimulation of a peripheral
nerve. SSEPs are obtained by weak sensory stimuli ideal for
disclosing sensitization (reflected by an increased response
amplitude to single or low numbers of stimuli) and habituation
(reflected by a decrease in average response amplitude after
high numbers of stimuli) [13, 14]. Using SSEPs, lack of both
habituation and sensitization can be disclosed in migraine
patients between attacks [15]. We recently studied SSEP
sensitization and habituation in migraine patients with MOH
(n=29) by comparison with episodic migraine, recorded
during (n=23) and outside (n=41) of an attack, and healthy
subjects (n=42; Fig. 1a) [16••].
We managed to record SSEPs in MOH patients in a
pain-free state or when experiencing only mild headaches.
We observed that amplitude of the most prominent SSEP
component, N20-P25, was initially (1st block) greater in
MOH patients and in episodic migraineurs without aura
studied ictally than in the subgroup studied interictally and
healthy controls [16••]. In control subjects and migraineurs
without aura studied ictally, N20-P25 habituation was
normal while it was clearly reduced in MOH and in
migraine without aura patients recorded interictally. The
increased SSEP amplitude in MOH was proportional to the
duration of headache chronification. We interpreted these
results as reflecting reinforcement and perpetuation of
94 Curr Pain Headache Rep (2012) 16:93–100
central sensitization due to the medication overuse and
increased headache frequency [16••]. As a further thought-
provoking result, we noted that the SSEP changes differed
according to the class of drugs overused; amplitudes were
smaller in triptan overusers than in patients overusing
NSAIDs or both medications combined, although both
groups had the same lack of habituation during repeated
stimulations.
Contingent Negative Variation
Contingent negative variation (CNV) is a slow cortical
potential related to higher mental functions, which consists
of a negative wave generated in a reaction-time paradigm.
Its early component (related to the warning stimulus) may
represent the level of expectation and it is supposed to be
modulated by the noradrenergic system, while its late
component is thought to be related to motor readiness and
to be under dopaminergic control [17].
Siniatchkin et al. [18] studied CNV amplitude and
habituation in a group of 15 patients with CDH and
analgesic overuse evolving from episodic migraine without
aura (also called “transformed migraine”) and for compar-
ison in 15 episodic migraineurs and 15 healthy controls.
Amplitude of total CNV and its early component was
greater in episodic migraine patients than in CDH patients
or controls. CDH patients had a smaller late CNV
component and an enhanced post-imperative negative
variation (PINV). The early CNV component did not
habituate in episodic migraine or in CDH patients, but in
the latter, this was related to significantly lower amplitudes.
A positive relationship between PINV and self-rated
depressive mood was found only in CDH patients [18].
According to the authors, these results reflect poor abilities
Table 1 Synopsis of published electrophysiological studies in chronic migraine and medication-overuse headache





de Tommaso et al. [9] 25 CM LEP N2-P2 amplitude Nonsignificant trend for excessive increase in
N2-P2 amplitudes, less obvious with increasing
painfulness of the stimulus and longer disease
duration
de Tommaso et al. [11] 16 CM LEP Brain mapping analysis of
the cortical source of the
P2 peak
Greater activation of the rostral portion of the
anterior cingulate cortex in CM patients
compared to EM and normal controls
Ayzenberg et al. [12] 29 MOH (14 NSAIDs
and 14 triptans)
PREP, nBR N2-P2 amplitude Increase in PREP amplitudes in all patients with
CM, normalizing after drug withdrawal. Normal
nBR
Coppola et al. [16••] 29 MOH (9 triptans,
10 NSAIDs, and 10 both
medications combined)
SSEP N20-P25 amplitude 1st block amplitudes greater in MOH than in
interictal episodic migraine and healthy
volunteers. Habituation deficit in MOH and
interictal migraine. Amplitudes smaller in triptan
overusers than in patients overusing NSAIDs or
both medications combined
Siniatchkin et al. [18] 15 TM CNV Amplitude of early
(CNV1) and late
(CNV2) components
Low-amplitude CNV1 and lack of habituation In
TM. Reduction of CNV2 and increase of post-
imperative negative variation, the latter related to
depressive mood
Chen et al. [19••] 25 CM VEF P100m amplitude 1st block amplitude higher in CM and ictal EM
compared to interictal EM. Normal habituation
in CM, ictal EM, and control subjects, contrasting
with lack of habituation in interictal EM
Chen et al. [20] 18 CM VEF P100m amplitude Normal habituation in CM patients. Lack of
habituation in patients with persistent visual aura
Aurora et al. [22] 25 CM TMS MSPA Lower subjective phosphene threshold and smallest
visual suppression index in CM compared to EM
and control subjects
Currà et al. [24] 40 MOH (10 triptans,
13 NSAIDs, and
17 combined)
TMS CSP duration CSP duration normal in MOH overall, while it was
reduced interictally in EM. CSP reduced in triptan
overusers compared to patients overusing
NSAIDs or triptans and NSAIDs combined. After
withdrawal, increase of CSP in combined
overusers; no change in triptan overusers
CM chronic migraine, CNV contingent negative variation, CSP cortical silent period, EM episodic migraine, LEP laser evoked potentials, N2-P2
negative-positive biphasic wave, nBR nociceptive specific blink reflex, NSAIDs nonsteroidal anti-inflammatory drugs, MOH medication-overuse
headache, MSPA magnetic suppression of perceptual accuracy, PREP pain-related evoked potentials, SSEP somatosensory evoked potentials, TM
transformed migraine, TMS transcranial magnetic stimulation, VEF visual evoked magnetic fields
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to cope with environmental demands and susceptibility for
depression in CDH patients. They also suggested that the
late CNV component and PINV may be predictive variables
for transformation of migraine.
Visual Evoked Potentials
The standard method for assessing excitability in the
occipital cortex is to record visual evoked potentials (VEPs;
ie, the electrical cortical response to structured visual
stimuli). The occipital cortex lies outside the “pain matrix”;
hence, it is supposedly unrelated to pain processing.
To search if the VEP abnormalities known to be present
in episodic migraine interictally, notably lack of habitua-
tion, would be present in CM patients, Chen et al. [19••]
recorded visual evoked magnetic fields (VEF) using
magnetoencephalography (MEG) in 25 CM patients and
compared them to 38 episodic migraineurs (29 interictally,
9 ictally) and 32 healthy controls. CM patients were
recorded in a pain-free interval. Grand average P100m
amplitudes as well as the 1st block amplitude were
significantly larger in CM patients and ictal episodic
migraine patients compared to interictal episodic migraine
subjects. On stimulus repetition, P100m amplitude habituated
equally in CM patients, ictal episodic migraine patients, and
control subjects, whereas a habituation deficit was recorded
interictally in episodic migraineurs. In patients with CM and
interictal episodic migraine, the P100m parameters did not
correlate with any clinical variable [19••]. That VEF
habituation is normal in CM (n=18) was confirmed by the
same authors in another study, where they found on the
contrary that the VEF potentiates in patients with persistent
visual aura (n=6) [20].
Transcranial Magnetic Stimulation
Transcranial magnetic stimulation (TMS) allows noninva-
sive exploration of the excitability of certain cortical areas
Fig. 1 Illustrative traces of a somatosensory evoked potentials
habituation (SSEP) and b cortical silent period (CSP) in a healthy
volunteer, an MOH patient overusing NSAIDs, and an MOH patient
overusing a triptan. Note absence of SSEP habituation in both
patients, but increased amplitude in block 1 in the NSAID overuser
contrasting with decreased amplitude in the triptan overuser. CSP is
reduced in the former, but more so in the latter. MOH—medication-
overuse headache
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and durable modification via repetitive stimulations
(rTMS).
In the method called magnetic suppression of perceptual
accuracy (MSPA), a series of three-letter trigrams are
presented on a computer screen and followed at variable
intervals by a single TMS pulse over the occipital area that
alters the perception accuracy. Aurora et al. [21], backing
up their preliminary study of a small group of five patients
with probable CM, applied the MSPA paradigm to study
cortical inhibition in 25 CM patients (with or without
medication overuse) and, for comparison, in episodic
migraine patients and healthy controls. CM patients had
the lowest subjective phosphene threshold and the smallest
suppression index, while healthy controls had the high-
est threshold and the largest suppression and episodic
migraineurs fell in between those two groups [22]. Out
of these 25 CM patients, 10 underwent an 18 F-
fludeoxyglucose positron emission tomography scan,
which showed increased metabolism in the pons and right
temporal cortex, contrasting with decreased metabolism in
bilateral medial frontal, parietal, and somatosensory areas
and caudate nuclei [22].
Interestingly, considering that the dorsolateral prefrontal
cortex (DLPFC) exerts an inhibitory control on pain
pathways in humans, Brighina et al. [23] explored the
effect of 12 daily sessions of high-frequency rTMS over the
left DLPFC in a small sham-controlled study of 11 CM
patients. They found a long-lasting reduction in attack
frequency, number of tablet intake, and headache index in
the effectively treated (n=6) compared to the sham-treated
group (n=5).
Assuming that medication overuse in headache patients
alters the balance between inhibition and excitation in the
cerebral cortex, we explored cortical inhibitory circuits by
measuring the TMS-induced cortical silent period (CSP)
[24]. The CSP is an interruption of voluntary muscle
activity induced by a high-intensity magnetic pulse deliv-
ered over the motor cortex. The CSP elicited in facial
muscles originates solely in the cortex [25]. CSP was
recorded in 40 MOH patients (10 triptan overusers, 13
NSAIDs overusers, and 17 triptan and NSAID overusers)
and, for comparison, in 12 episodic migraineurs between
attacks and 13 healthy subjects. CSP duration was reduced
interictally in episodic migraineurs, but normal in the total
group of MOH patients. However, analysis of subgroups
showed that CSP duration was significantly shorter in
triptan overusers than in the NSAID or triptan plus NSAID
overuser groups (Fig. 1b). In 10 patients who overcon-
sumed both triptans and NSAIDs, the CSP shortened and
reached normal values 3 weeks after drug withdrawal. By
contrast, in eight triptan overusers, there was no change in
CSP duration after withdrawal. In MOH patients overall,
CSP duration correlated positively with monthly tablet
intake. However, this positive correlation was restricted to
NSAID and triptan plus NSAID MOH subgroups; triptan
overusers showed an inverse relationship [24].
Conclusions
To summarize, clinical neurophysiology has shown that
cortical responsivity in migraine fluctuates over time not
only in relation to the cycle of the migraine attacks
(preictal/ictal/interictal), but also in relation to attack
frequency. The most reproducible abnormality of evoked
potentials, namely lack of habituation, is detectable during
the pain-free interval and it is usually accompanied by a
low response amplitude after low numbers of stimuli (1st
block amplitude). By contrast, during the attack (ie, ictally),
habituation and 1st block amplitude increase and normalize,
while during the days immediately preceding the attack (ie,
preictally), the habituation deficit further worsens. We have
postulated that these cortical electrophysiological patterns
are related to changes in serotonin transmission, which is
low interictally [26], and may further decrease preictally but
increase ictally, as suggested by several biochemical studies
[27, 28] and numerous imaging studies [29, 30] showing
activation of pontomesencephalic areas comprising mono-
aminergic nuclei during migraine attacks (see [6] for a
review).
In CM patients, brainstem activation was found in
similar locations as during migraine attacks [5, 22, 31].
Moreover, in CM with or without medication-overuse,
electrophysiological studies have shown abnormalities that
are also reported during attacks in episodic migraineurs
(Table 2). These abnormalities tend overall to indicate an
increase in cortical excitability, in particular of somatosen-
sory and visual cortices, reflected by an increased ampli-
tude of evoked cortical responses, decreased activity of
inhibitory cortical interneurons reflected in the smaller
MSPA [22], and, at least for VEPs, an increase in
habituation. This suggests that from an electrophysiological
point of view, CM looks like a “never ending migraine
attack” [32].
We have shown before that 1st block amplitude and
habituation are directly correlated as far as VEPs are
concerned [33]. This appears to hold true in CM without
drug overuse for visual evoked responses, but not in MOH
for SSEP [16••], where amplitude was increased and
habituation decreased. The discrepancy between the two
studies could be due to the fact that they explore two
different sensory systems and that plastic changes occurring
during chronic headache predominate in areas belonging to
the pain matrix, and thus, in the somatosensory cortex.
However, a more likely explanation is that the difference is
due to brain effects of the prolonged overuse of drugs in the
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SSEP study. This also may explain why habituation
remains abnormal in the CNV study of patients with
MOH [18]. Our observation that the increased grand
average SSEP amplitude in MOH was proportional to the
duration of the chronic headache phase [16••] would favor
this explanation, as does our unpublished finding that SSEP
habituation is normal in CM patients without medication
overuse.
From a physiological point of view, evoked-potential
amplitude to low numbers of stimuli is a marker of
sensitization, while amplitude reduction over large numbers
of stimuli reflects habituation (or adaptation). Both phe-
nomena are considered to be partially independent and,
therefore, can be differentially affected by pharmacological
interventions [14, 42]. As a matter of fact, in our MOH
patients, NSAIDs overuse induced SSEP sensitization
(increased 1st amplitude block) that persisted over time
(lack of habituation), while triptans reduced both sensitiza-
tion and habituation, although we suspect that in this case,
the reduction in habituation is chiefly due to the low initial
amplitudes causing a “low ceiling” effect [16••]. We also
have found that triptans and NSAIDs, when overused,
differently influence excitability of the somatosensory and
the motor cortices. While NSAID overuse appears to
promote sensitization in the sensory system, triptan overuse
does not, but it reduces inhibitory mechanisms in the motor
cortex in proportion to the degree of overconsumption [24].
The biological explanation for this difference is not known,
but it is likely related to the different pharmacological
actions and targets of these drugs. The clinical differences
between NSAID- and triptan-overuse headaches are well
known [43] and they were shown to have different effects
on the trigeminal system after repeated administration in
experimental animals [44]. It remains to be shown if there
is a relation between experimental findings and clinical
features. Meanwhile, it is of interest that NSAID overuse
induces sensitization in the somatosensory system and that
it also is associated with a longer duration of withdrawal
headaches compared to triptans [45].
Increased amplitude of non-noxious (SSEP and VEP)
and noxious (LEP and PREP) evoked responses probably
reflect central sensitization. Central sensitization may
indeed play an important role in the pathophysiology of
headache chronification. While it is supposed to occur
transiently during the migraine attack and to manifest itself
clinically as cutaneous allodynia [34] and neurophysiolog-
ically as an increase in trigeminal reflexes [35], there is
some evidence that it may be more persistent in CM where
allodynia, for example, is highly prevalent [36, 37]. It has
been hypothesized that a condition characterized by a
continuous painful state, such as the daily headache of CM
and MOH patients, leads to a permanent dysfunction of the
Table 2 Synoptic table of electrophysiological changes comparing episodic migraine (between and during attacks) and chronic migraine with or
without medication overuse
Episodic migraine (interictal) Episodic migraine (ictal) Chronic migraine/MOH
Amplitude Habituation Amplitude Habituation Amplitude Habituation
LEP




NSBR N , j j N
SSEP , (1st block) , j j j (NSAIDs) ,
N (triptans)
CNV
Early j , , j , (1st block) , (PINV j)
Late N N , (BDI: 21)
VEP
Electric , (1st block) , j (1st block) j j j
Magnetic , , j j
Cortical silent period (TMS) , N (NSAIDs)
, (triptans)
The differences between chronic migraine patients with and without medication overuse described in the text are not shown
Arrows indicate the direction of change, BDI Beck Depression Inventory score, CNV contingent negative variation, LEP laser evoked potential,
MOH medication-overuse headache, N normal, NSAIDs nonsteroidal anti-inflammatory drugs, NSBR nociception-specific blink reflex, PINV post-
imperative negative variation, PREP pain-related evoked potential, SSEP somatosensory evoked potential, TMS transcranial magnetic stimulation,
VEP visual evoked potential
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antinociceptive modulatory pathways [38]. Central sensiti-
zation could be associated with plastic changes in various
cerebral areas belonging to the so-called pain matrix [39,
40] that could be reflected neurophysiologically by the
anatomical shifts found in the pain-activated cortical areas
in the previously described LEP study of CM patients [11].
Central sensitization in the pain network is associated with
abnormal neuronal excitability, causing a decrease in
nociceptive thresholds, an increased responsiveness to both
noxious and innocuous peripheral stimuli, and an expansion
of the receptive fields of nociceptors [41]. It is of
pathophysiological interest that central sensitization, as
suggested by increased amplitudes of PREPs, seems to be
generalized and suprasegmental because nociception-specific
blink reflexes were normal in MOH patients [9, 12].
VEF habituation in CM [19••, 20] and SSEP lack of
habituation in MOH [16••] are independent of the
presence or intensity of headache at the time of recording.
This clearly argues against the hypothesis that cortical
changes in CM/MOH are a nonspecific consequence of
ongoing pain [46].
To conclude, the methods of clinical neurophysiology
are particularly appropriate to improve noninvasively our
understanding of the cortical and brainstem dysfunctions
associated with migraine and with its chronification by
medication overuse. However, further research is necessary
and should include more detailed studies taking into
account the differences between pharmacological classes
and between migraine chronification with and without
medication overuse. New insight also can be gained by
studies combining electrophysiology and functional brain
imaging.
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